These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9628841)

  • 41. The Fractional Differential Model of HIV-1 Infection of CD4
    Lichae BH; Biazar J; Ayati Z
    Comput Math Methods Med; 2019; 2019():4059549. PubMed ID: 30728851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug-resistant genotyping in HIV-1 therapy.
    Aboulker JP
    Lancet; 1999 Sep; 354(9184):1120. PubMed ID: 10509521
    [No Abstract]   [Full Text] [Related]  

  • 43. A novel antiviral approach.
    Arancio W
    Med Hypotheses; 2012 Sep; 79(3):396-9. PubMed ID: 22749380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mathematical analysis of delay differential equation models of HIV-1 infection.
    Nelson PW; Perelson AS
    Math Biosci; 2002; 179(1):73-94. PubMed ID: 12047922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multidrug Therapy for HIV Infection: Dynamics of Immune System.
    Kamboj D; Sharma MD
    Acta Biotheor; 2019 Jun; 67(2):129-147. PubMed ID: 30515609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A two-strain hiv-1 mathematical model to assess the effects of chemotherapy on disease parameters.
    Shiri T; Garira W; Musekwa SD
    Math Biosci Eng; 2005 Oct; 2(4):811-32. PubMed ID: 20369954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection.
    Weinberger LS; Schaffer DV; Arkin AP
    J Virol; 2003 Sep; 77(18):10028-36. PubMed ID: 12941913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modelling Optimal Control of In-Host HIV Dynamics Using Different Control Strategies.
    Ngina P; Mbogo RW; Luboobi LS
    Comput Math Methods Med; 2018; 2018():9385080. PubMed ID: 29971134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach.
    Shirreff G; Pellis L; Laeyendecker O; Fraser C
    PLoS Comput Biol; 2011 Oct; 7(10):e1002185. PubMed ID: 22022243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The gift of a lifetime: analysis of HIV at autopsy.
    Maldarelli F
    J Clin Invest; 2020 Apr; 130(4):1611-1614. PubMed ID: 32091411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Global stability of models of humoral immunity against multiple viral strains.
    Inoue T; Kajiwara T; Sasaki T
    J Biol Dyn; 2010 May; 4(3):282-95. PubMed ID: 22873364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mathematical model for treatment-resistant mutations of hiv.
    Moore H; Gu W
    Math Biosci Eng; 2005 Apr; 2(2):363-80. PubMed ID: 20369928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Viral and Cellular Dynamics in HIV Disease.
    Bucy RP
    Curr Infect Dis Rep; 2001 Jun; 3(3):295-301. PubMed ID: 11384561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mathematical modeling of immunological reactions.
    Morel PA
    Front Biosci; 1998 Mar; 3():d338-7. PubMed ID: 9495835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulating Immune Response in Viral Infection for Quantitative Forecasts of Drug Efficacy.
    Costa B; Vale N
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viral Decay Dynamics and Mathematical Modeling of Treatment Response: Evidence of Lower in vivo Fitness of HIV-1 Subtype C.
    Shet A; Nagaraja P; Dixit NM
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):245-251. PubMed ID: 27273158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs.
    Koizumi Y; Iwami S
    Theor Biol Med Model; 2014 Sep; 11():41. PubMed ID: 25252828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrophages and their relevance in Human Immunodeficiency Virus Type I infection.
    Koppensteiner H; Brack-Werner R; Schindler M
    Retrovirology; 2012 Oct; 9():82. PubMed ID: 23035819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Applying the epidemiologic problem oriented approach (EPOA) methodology in developing a knowledge base for the modeling of HIV/AIDS.
    Nganwa D; Habtemariam T; Tameru B; Gerbi G; Bogale A; Robnett V; Wilson W
    Ethn Dis; 2010; 20(1 Suppl 1):S1-173-7. PubMed ID: 20521410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Bayesian Approach in Differential Equation Dynamic Models Incorporating Clinical Factors and Covariates.
    Huang Y
    J Appl Stat; 2010 Feb; 37(2):181-199. PubMed ID: 20445811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.